Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
How CDM Is Evolving to Counter Emerging Cyber Threats
CISA’s Acting Associate Director for Capacity Building and CDM Program Director discusses how the program is now tackling threat mitigation.
31m watch -
Edge AI Brings Faster Decision-Making to Federal Missions
Edge AI can help process data faster in dispersed environments such as battlefield medicine, satellites and wildfires.
4m read -
Who’s in Charge of AI and SI at Top Federal Agencies
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read -
Federal CISO's Four Priorities to Strengthen Cybersecurity
Federal CISOs are shifting toward proactive risk management as rapidly advancing AI capabilities increase pressure on agencies to modernize.
3m read
